CO - Global Cord Blood

$CO.US$ I am surprised that this company has not rocket up its price given the importance of cord blood to treat various sickness and stem cells transplant for various uses. it is a shame that the price is stagnant below 5 dollars.
Earnings result will be on 1st March. Hope it will drive up the price to above 6 dollars or more. With advance technology in China, stem cells and cord blood should be lucrative business but not sure what went wrong in not driving up the price.